A Rare Childhood Disease Finally Mapped
Duke Children's Hospital pinpoints genetic cause and disease course of alternating hemiplegia of childhood, a rare pediatric neurological disorder.
Catching a fungal enzyme open for business
Serious fungal infections are on the rise, and many hospital-acquired cases are becoming harder to treat as fungi become resistant to available medications.
Four Duke leaders named as inaugural Fellows of ACTS
The Association for Clinical and Translational Science (ACTS) fellows program recognizes individuals who have made substantial contributions to and service within the clinical and translational science field and who are an essential part of the clinical and translational community.
A Student-Led Push to Rethink Heart Healing
Some tissues, like liver and skeletal muscle, can regenerate after injury and can go back to functioning normally. Heart tissue, though, typically scars after injury.
A new kind of house call: First-of-its-kind telehealth program transforms care for homebound patients
Duke University medical students launched a first-of-its-kind telehealth program that transformed the way primary care is delivered to low-income older, homebound adults, and those with disabilities in Durham.
Pioneering the next generation of genetic therapies
Duke investigators are advancing gene and genome editing approaches to treat Pompe disease and glycogen storage disorders.
Gift strengthens patient care today, trains radiology leaders for tomorrow
Duke University alumnus and second-generation physician Vijay Ramakrishnan, MD and his wife, Praveena Ramakrishnan, have made a unique $3 million gift that supports both Duke University Health System patients and School of Medicine radiology residents. Practicing medicine runs deep in the Ramakrishnan family — and now, their legacy is helping shape the future of radiology at Duke.
How to build a brain
Researchers at Duke University School of Medicine have uncovered a previously unknown role for astrocytes in shaping the developing brain. By sending different signals to immune cells, these star-shaped cells help decide which neural connections stay and which ones are pruned away.
Duke researchers discover cellular ‘release valve’ that could strengthen bones and cartilage
Scientists have identified a long‑sought enzyme that controls a fundamental chemical process critical for healthy bones and cartilage, according to a study accepted to Nature Chemical Biology. The study opens the door to drug development, suggesting that inhibiting MESH1 could help restore sulfation in patients with related diseases.
Young Minds Tackling Old Questions
The next generation of researchers are driving discoveries focused on ensuring longer lives are healthier, more active, and more vital.